Emily Hewson

Title: Emily Hewson: Innovator in Radiation Therapy Optimization

Introduction

Emily Hewson is a prominent inventor based in Sydney, Australia. She has made significant contributions to the field of radiation therapy through her innovative patent. Her work focuses on optimizing multi-leaf collimator (MLC) tracking, which is crucial for enhancing the precision of radiation treatments.

Latest Patents

Emily holds a patent titled "Dose-based optimization for multi-leaf collimator ('MLC') tracking during radiation therapy methods and apparatus." This patent outlines methods, apparatuses, and systems for dose-based optimization related to MLC tracking during radiation therapy. The method includes calculating a planned radiation dose using an MLC plan in an un-shifted dose volume. It also involves acquiring a target position through motion tracking and shifting the dose volume accordingly. Furthermore, the method integrates a three-dimensional dose into a two-dimensional beam's eye view grid and fits an MLC aperture by minimizing a cost function. The process culminates in calculating and accumulating a delivered dose based on the fitted leaf positions of the MLC and updating the gantry position and MLC leaves for the next planned dose.

Career Highlights

Emily is affiliated with The University of Sydney Commercial Development & Industry Partnerships. Her role at this institution allows her to bridge the gap between academic research and practical applications in the medical field.

Collaborations

Emily has collaborated with notable colleagues, including Lars Mejnertsen and Paul Keall. Their combined expertise contributes to advancements in radiation therapy technologies.

Conclusion

Emily Hewson's innovative work in radiation therapy optimization exemplifies the impact of dedicated inventors in the medical field. Her contributions are paving the way for more effective treatment methods, ultimately benefiting patients worldwide.